Central Nervous System

Curio wins FDA approval for its postpartum depression digital therapeutic

Curio Digital Therapeutics has received 510(k) clearance from the US Food and Drug Administration (FDA) for its prescription digital therapeutic…

Hyperfine starts enrolment in portable imaging workflow study

US-based health technology company Hyperfine has enrolled the first patient in the clinical workflow study of its US Food and…

Roche wins breakthrough designation for Tau biomarker test for Alzheimer’s

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Roche’s Elecsys pTau217 plasma biomarker assay. The…

SpineX eyes FDA submission as neurogenic bladder trial hits milestone

SpineX has closed recruitment for a clinical study investigating its neuromodulation device to treat urinary incontinence. Data from the trial,…

Neuronetics’s NeuroStar wins FDA clearance for adolescents with depression

The US Food and Drug Administration (FDA) has granted clearance to Neuronetics for its NeuroStar device as an add-on therapy…

Developer behind wearable device for Tourettes syndrome secures $3.2m

Neupulse, a UK-based company that is developing a wristband to help manage the symptoms of Tourette's syndrome, has raised $3.2m…

SetPoint wins second FDA breakthrough device nod for neurostim device

SetPoint Medical has a breakthrough device designation for its neuroimmune modulation device for the treatment of relapsing-remitting multiple sclerosis (RRMS).…

Sooma raises $5.5m to expand access for neuromodulation device

Finland-based Sooma Medical has raised €5m ($5.5m) in venture funding to expand market access for its transcranial direct current stimulation…

Helping advance earlier CTE diagnosis in NFL players

More than 100 million people watched the Kansas City Chiefs beat the San Francisco 49ers in the Super Bowl LVIII,…

Viz.ai’s aneurysm diagnostic tool is 97.2% predictive in ruling out stroke

US-based Viz.ai has released new trial data that assessed its artificial intelligence (AI) powered neurovascular technology to detect and diagnose…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close